Rodolphe Fischmeister

Years Active: 2017-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Candice Sartre, François Peurois, Marie Ley, Marie-Hélène Kryszke, Wenhua Zhang, Delphine Courilleau, Rodolphe Fischmeister, Yves Ambroise, Mahel Zeghouf, Sarah Cianférani, Yann Ferrandez, Jacqueline Cherfils
Membranes prime the RapGEF EPAC1 to transduce cAMP signaling. Nature communications 14 (1) (2023)
Marianne Mazevet, Anissa Belhadef, Maxance Ribeiro, Delphine Dayde, Anna Llach, Marion Laudette, Tiphaine Belleville, Philippe Mateo, Mélanie Gressette, Florence Lefebvre, Ju Chen, Christilla Bachelot-Loza, Catherine Rucker-Martin, Frank Lezoualch, Bertrand Crozatier, Jean-Pierre Benitah, Marie-Catherine Vozenin, Rodolphe Fischmeister, Ana-Maria Gomez, Christophe Lemaire, Eric Morel
EPAC1 inhibition protects the heart from doxorubicin-induced toxicity. eLife 12 (2023)
Rima Kamel, Jérôme Leroy, Grégoire Vandecasteele, Rodolphe Fischmeister
Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure. Nature reviews. Cardiology (2022)
Rimantas Treinys, Giedrius Kanaporis, Rodolphe Fischmeister, Jonas Jurevičius
Metabolic Inhibition Induces Transient Increase of L-type Ca2+ Current in Human and Rat Cardiac Myocytes. International journal of molecular sciences 20 (6) (2019)
Giedrius Kanaporis, Rimantas Treinys, Rodolphe Fischmeister, Jonas Jurevičius
Metabolic inhibition reduces cardiac L-type Ca2+ channel current due to acidification caused by ATP hydrolysis. PloS one 12 (8) (2017)

Rodolphe Fischmeister.css-eqlu8i{font-size:small;padding-left:4px;}